Zach Collins
Partner at Mission BioCapital
San Francisco Bay Area
Overview
Work Experience
Partner
2024 - Current
Principal
2021 - 2024
Associate
2019 - 2021
Analyst
2018 - 2019
Mission BioCapital is a life science venture capital firm that invests in early-stage companies.
Raised $11,000,001.00.
Entrepreneur Success Partner
2020
MBC BioLabs is the premier biotech incubator in the Bay Area.
Chief Business Officer
2022
Alessa Therapeutics develops localized treatments for solid organ disease.
Raised $6,264,997.00 from Mission BioCapital.
Board Observer
2021
Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.
Raised $208,000,000.00 from Norwest Venture Partners, Blue Owl, Mission BioCapital, Lotte, Cowen Healthcare Investments, Bristol-Myers Squibb, Alexandria Venture Investments, Sanofi Ventures, Global BioAccess Fund and Abrdn.
Board Obsever
2021
Board Member
2021
Postdoctoral Research Fellow
2018 - 2018
Graduate Student Researcher
2013 - 2018
• Uncovered a novel genetic feedback mechanism regulating the differentiation of neural stem cells • Designed and developed CRISPR Cas9 based genome engineering techniques • Collaborated on research projects using cutting edge light-sheet microscopy and single cell genomics
Team Member
2017 - 2018
• Performed market research for a CAR T-cell therapy being developed at the Dana-Farber Cancer Institute • Presented due-diligence and regulatory strategy findings to a team of scientists and entrepreneurs
Undergraduate Research Program Student
2012 - 2012
Undergraduate Researcher
2010 - 2012